Explore
Validate
LearnMA1-19639
antibody from Invitrogen Antibodies
Targeting: CD59
16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Flow cytometry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA1-19639 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CD59 Monoclonal Antibody (MEM-43), PE
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- This antibody reacts with well defined epitope (W40, R-53) on CD59 (Protectin), an 18-20 kDa glycosylphosphatidylinositol (GPI)-anchored glycoprotein expressed on the surface of all hematopoietic cells; it is widely present on cells in all tissues. This antibody does not compete with MEM-43/5, and has blocking activity.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Yellow dye
- Isotype
- IgG
- Antibody clone number
- MEM-43
- Vial size
- 100 Tests
- Storage
- 4° C, store in dark, DO NOT FREEZE!
Submitted references Rare event counting of CD59- red cells in human blood: A 47-month experience using PNH consensus guidelines for WBC and RBC testing in a reference lab.
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.
Increased expression of phosphatidylinositol-specific phospholipase C resistant prion proteins on the surface of activated platelets.
Increased expression of phosphatidylinositol-specific phospholipase C resistant prion proteins on the surface of activated platelets.
Liew M, Farley M, Andreasen J, Parker CJ, Wittwer CT
Cytometry. Part B, Clinical cytometry 2015 Jul-Aug;88(4):261-9
Cytometry. Part B, Clinical cytometry 2015 Jul-Aug;88(4):261-9
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.
Williams ME, Densmore JJ, Pawluczkowycz AW, Beum PV, Kennedy AD, Lindorfer MA, Hamil SH, Eggleton JC, Taylor RP
Journal of immunology (Baltimore, Md. : 1950) 2006 Nov 15;177(10):7435-43
Journal of immunology (Baltimore, Md. : 1950) 2006 Nov 15;177(10):7435-43
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.
Williams ME, Densmore JJ, Pawluczkowycz AW, Beum PV, Kennedy AD, Lindorfer MA, Hamil SH, Eggleton JC, Taylor RP
Journal of immunology (Baltimore, Md. : 1950) 2006 Nov 15;177(10):7435-43
Journal of immunology (Baltimore, Md. : 1950) 2006 Nov 15;177(10):7435-43
Increased expression of phosphatidylinositol-specific phospholipase C resistant prion proteins on the surface of activated platelets.
Holada K, Mondoro TH, Muller J, Vostal JG
British journal of haematology 1998 Oct;103(1):276-82
British journal of haematology 1998 Oct;103(1):276-82
Increased expression of phosphatidylinositol-specific phospholipase C resistant prion proteins on the surface of activated platelets.
Holada K, Mondoro TH, Muller J, Vostal JG
British journal of haematology 1998 Oct;103(1):276-82
British journal of haematology 1998 Oct;103(1):276-82
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Flow cytometry analysis of CD59 using a monoclonal antibody (Product # MA1-19639).
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Flow cytometry analysis (surface staining) of HL-60 (red) and SP2 (blue) cells with anti-human CD59 (MEM-43) PE Monoclonal antibody (Product # MA1-19639). Blank samples are shown orange (HL-60) and green (SP2).
- Conjugate
- Yellow dye
